At a glance
- Originator Nippon Organon
- Class Anti-inflammatories
- Mechanism of Action Selectin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Dermatitis
Most Recent Events
- 22 Sep 1998 No-Development-Reported for Dermatitis in Japan (unspecified route)
- 22 Oct 1996 Preclinical development for Dermatitis in Japan (unspecified route)